Overview
Valerie Lee, M.D., is a medical oncologist with the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor of medical oncology at Johns Hopkins University School of Medicine. Dr. Lee has an expertise in management of gastrointestinal malignancies, including gastric, colon and pancreatobiliary cancers. Dr. Lee earned her medical degree from the Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine at New York Presbyterian Hospital, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine. Dr. Lee is currently earning her Certificate in Science of Clinical Investigation at Johns Hopkins Bloomberg School of Public Health. Dr. Lee is a member of the American Society of Clinical Oncology. Dr. Lee manages multiple early phase trials and her work has been published in peer-reviewed journals. Her research interests include clinical trials for patients with gastrointestinal malignancies, and combining traditional chemotherapies with immunotherapy to improve survival and quality of life for patients. She has received a Cancer Center Training grant for research on molecular targets for cancer detection and treatment and has spoken at numerous conferences on updates in gastrointestinal malignancies.
Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Liver Cancer. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Pancreaticoduodenectomy.
Her clinical research consists of co-authoring 26 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Liver Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5255 Loughboro Road Northwest, Building B, Building B, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Skip Viragh Outpatient Cancer Center
Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.
Uva Community Health Medical Group LLC
Pranav Patel is an Oncologist and a Hematologist in Culpeper, Virginia. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Liver Cancer, Anemia, Paget Disease of the Breast, Endoscopy, and Colonoscopy. Dr. Patel is currently accepting new patients.
Elizabeth Jaffee is an Oncologist in Baltimore, Maryland. Dr. Jaffee is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Lee isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Colorectal CancerDr. Lee isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Lee isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Lee isDistinguished. Learn about Familial Pancreatic Cancer.
- Neuroendocrine TumorDr. Lee isDistinguished. Learn about Neuroendocrine Tumor.
- Pancreatic CancerDr. Lee isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Ampullary CancerDr. Lee isAdvanced. Learn about Ampullary Cancer.
- Anal CancerDr. Lee isAdvanced. Learn about Anal Cancer.
- Appendix CancerDr. Lee isAdvanced. Learn about Appendix Cancer.
- Gastroesophageal Junction Cancer
- Lynch SyndromeDr. Lee isAdvanced. Learn about Lynch Syndrome.
- PancreatoblastomaDr. Lee isAdvanced. Learn about Pancreatoblastoma.
- Experienced
- AgranulocytosisDr. Lee isExperienced. Learn about Agranulocytosis.
- Desmoid TumorDr. Lee isExperienced. Learn about Desmoid Tumor.
- Fibrolamellar CarcinomaDr. Lee isExperienced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Lee isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Lee isExperienced. Learn about Gallbladder Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)